Business Wire
Quince Therapeutics Announces Last Patient Last Visit in Phase 3 NEAT Clinical Trial in Patients with Ataxia-Telangiectasia
📈
AI Sentiment
Highly Positive
8/10
Quince Therapeutics Inc. News
Latest updates and market news for QNCX
2 news
Dec 10 - Dec 16, 2025
Page 1
Business Wire
Quince Therapeutics Announces Publication of Use of eDSP in Early-Stage Clinical Studies in Pulmonary and Inflammatory Bowel Disorders
📈
AI Sentiment
Highly Positive
8/10
Share this news page